Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SATB2 in Combination With Cytokeratin 20 Identifies Over 95% of all Colorectal Carcinomas

15 Jun 2011

Abstract excerpt

The special AT-rich sequence-binding protein 2 (SATB2), a nuclear matrix-associated transcription factor and epigenetic regulator, was identified as a tissue type-specific protein when screening protein expression patterns in human normal and cancer tissues using an antibody-based proteomics approach. In this respect, the SATB2 protein shows a selective pattern of expression and, within cells of epithelial...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Diagnosis and Treatment
Share to Genetic factors in colorectal cancer
Share to Metastasis and carcinoma case studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 21677534
DOI: 10.1097/pas.0b013e31821c3dae

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SATB2 in Combination With Cytokeratin 20 Identifies Over 95% of all Colorectal CarcinomasPMID 21677534Read ↗

SATB2 Expression in Human Tumors: A Tissue Microarray Study on More Than 15 000 TumorsSemantic proximity Read ↗

Loss of SATB2 Expression in Colorectal Carcinoma Is Associated With DNA Mismatch Repair Protein Deficiency and BRAF Mutation.Semantic proximity Read ↗

Small Bowel Adenocarcinomas Featuring Special AT-Rich Sequence-Binding Protein 2 (SATB2) Expression and a Colorectal Cancer-Like Immunophenotype: A Potential Diagnostic PitfallSemantic proximity Read ↗

SATB2 is a novel biomarker and therapeutic target for cancerSemantic proximity Read ↗

Multiple effects of the special AT‐rich binding protein 1 (SATB1) in colon carcinomaSemantic proximity Read ↗

Special AT-rich sequence-binding protein 2 acts as a negative regulator of stemness in colorectal cancer cells.Semantic proximity Read ↗

Loss of special <scp>AT</scp>‐rich sequence‐binding protein 1 (<scp>SATB</scp>1) predicts poor survival in patients with colorectal cancerSemantic proximity Read ↗

Metastatic colorectal carcinomas with high SATB2 expression are associated with better prognosis and response to chemotherapy: a population-based Scandinavian study.Semantic proximity Read ↗

Loss of SATB2 and CDX2 expression is associated with DNA mismatch repair protein deficiency and BRAF mutation in colorectal cancer.Semantic proximity Read ↗

SATB1 expression is associated with biologic behavior in colorectal carcinoma in vitro and in vivo.Semantic proximity Read ↗

SATB2 Induces Malignant Transformation and Cancer Stem Cell Characteristics, and Inhibition of Its Expression Reverses Drug Resistance in MesotheliomaSemantic proximity Read ↗

Differential Diagnostic Value of SATB2 in Primary Pulmonary Enteric Adenocarcinoma and Pulmonary Metastases of Colorectal CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.